New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
John Kellum, MD, FCCM, a professor at the University of Pittsburgh, discusses his article from the August 2007 issue of Critical Connections, "Preventing Acute Renal Failure."
John A. Kellum, MD, FCCM, discusses how one uses RIFLE to take care of patients with acute kidney injury (AKI). He also discusses his review article, published in the April 2008 Supplement issue of Critical Care Medicine, titled “Acute Kidney Injury.”
Todd Fraser, MD, speaks with John Kellum, MD, MCCM, Professor of Critical Care Medicine at the University of Pittsburgh in Pittsburgh, Pennsylvania. In this interview, Dr. Kellum discusses the concept of renal repair after acute kidney injury and its link to significant long-term outcomes in critically ill patients.
Ludwig Lin, MD, speaks with Azra Bihorac, MD, MS, FCCM, about the article, “Guiding AKI Prevention Using Biomarkers,” published in Critical Connections.
Todd Fraser, MD, speaks with Paul Young, FCICM, about the article, “Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial,” published in The Journal of the American Medical Association.
Dr. Fraser, MD, speaks with Bruce A. Mueller, PharmD, FCCP, FASN, about his talk presented at the 47th Critical Care Congress in San Antonio, Texas, entitled "Artificial Kidney Meets Mechanical Lung: Comanaging the Patient with Renal and Respiratory Failure."
Ludwig H. Lin, MD, and John A. Kellum, MD, MCCM, review factors associated with renal recovery, therapies and techniques used to enhance recovery, and long-term consequences of nonrecovery in critical illness.
Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature.
Ludwig H. Lin, MD, and Michael G.S. Shashaty, MD, MS, discuss acute kidney injury (AKI) biomarkers and whether they are ready for clinical use.
From Critical Care Medicine. The authors evaluated the prevalence, evolution, and clinical factors associated with acute kidney injury in children admitted to PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2.
Can the biomarkers identified in the Pediatric Sepsis Biomarker Risk Model (PERSEVERE II) be used to predict acute kidney injury and renal recovery in pediatric septic shock? This Concise Critical Appraisal explores a study in which Stanski et al (Am J Respir Crit Care Med. 2020;201:848-855) sought to answer this question.
Jaber et al (Lancet. 2018;392:31-40) set out to evaluate the effect of sodium bicarbonate infusion on critically ill patient outcomes.